CN105533696A - Powder type total-nutrient formula food for patients suffering from tumors - Google Patents
Powder type total-nutrient formula food for patients suffering from tumors Download PDFInfo
- Publication number
- CN105533696A CN105533696A CN201510947496.8A CN201510947496A CN105533696A CN 105533696 A CN105533696 A CN 105533696A CN 201510947496 A CN201510947496 A CN 201510947496A CN 105533696 A CN105533696 A CN 105533696A
- Authority
- CN
- China
- Prior art keywords
- powder
- nutritional formulas
- protein
- full nutritional
- type tumour
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 60
- 239000000843 powder Substances 0.000 title claims abstract description 23
- 235000013305 food Nutrition 0.000 title abstract description 20
- 235000016709 nutrition Nutrition 0.000 claims abstract description 52
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 23
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 11
- 239000003765 sweetening agent Substances 0.000 claims abstract description 11
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 10
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 9
- 239000011782 vitamin Substances 0.000 claims abstract description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 7
- 239000011707 mineral Substances 0.000 claims abstract description 7
- 235000018102 proteins Nutrition 0.000 claims description 21
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 16
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 15
- 229940013618 stevioside Drugs 0.000 claims description 15
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 15
- 235000019202 steviosides Nutrition 0.000 claims description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 14
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 14
- XWCYDHJOKKGVHC-UHFFFAOYSA-N Vitamin A2 Chemical compound OCC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C XWCYDHJOKKGVHC-UHFFFAOYSA-N 0.000 claims description 12
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 9
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 9
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 9
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 9
- 239000011575 calcium Substances 0.000 claims description 9
- 229910052791 calcium Inorganic materials 0.000 claims description 9
- 229910052802 copper Inorganic materials 0.000 claims description 9
- 239000010949 copper Substances 0.000 claims description 9
- 235000019197 fats Nutrition 0.000 claims description 9
- 239000011777 magnesium Substances 0.000 claims description 9
- 229910052749 magnesium Inorganic materials 0.000 claims description 9
- 239000011591 potassium Substances 0.000 claims description 9
- 229910052700 potassium Inorganic materials 0.000 claims description 9
- 239000011669 selenium Substances 0.000 claims description 9
- 229910052711 selenium Inorganic materials 0.000 claims description 9
- 239000011734 sodium Substances 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 8
- 235000014633 carbohydrates Nutrition 0.000 claims description 8
- 239000011630 iodine Substances 0.000 claims description 8
- 229910052740 iodine Inorganic materials 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 8
- 229910052748 manganese Inorganic materials 0.000 claims description 8
- 239000011572 manganese Substances 0.000 claims description 8
- 239000011574 phosphorus Substances 0.000 claims description 8
- 229910052698 phosphorus Inorganic materials 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 7
- 102000004407 Lactalbumin Human genes 0.000 claims description 7
- 108090000942 Lactalbumin Proteins 0.000 claims description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 7
- 108010073771 Soybean Proteins Proteins 0.000 claims description 7
- 235000019486 Sunflower oil Nutrition 0.000 claims description 7
- 229930003268 Vitamin C Natural products 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- 229960002685 biotin Drugs 0.000 claims description 7
- 235000020958 biotin Nutrition 0.000 claims description 7
- 239000011616 biotin Substances 0.000 claims description 7
- 229960000304 folic acid Drugs 0.000 claims description 7
- 235000019152 folic acid Nutrition 0.000 claims description 7
- 239000011724 folic acid Substances 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 239000000944 linseed oil Substances 0.000 claims description 7
- 235000021388 linseed oil Nutrition 0.000 claims description 7
- 235000012054 meals Nutrition 0.000 claims description 7
- 229960003512 nicotinic acid Drugs 0.000 claims description 7
- 235000001968 nicotinic acid Nutrition 0.000 claims description 7
- 239000011664 nicotinic acid Substances 0.000 claims description 7
- 229940055726 pantothenic acid Drugs 0.000 claims description 7
- 235000019161 pantothenic acid Nutrition 0.000 claims description 7
- 239000011713 pantothenic acid Substances 0.000 claims description 7
- 239000011772 phylloquinone Substances 0.000 claims description 7
- 235000019710 soybean protein Nutrition 0.000 claims description 7
- 239000002600 sunflower oil Substances 0.000 claims description 7
- 235000019154 vitamin C Nutrition 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- 235000019165 vitamin E Nutrition 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- 239000011709 vitamin E Substances 0.000 claims description 7
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims description 6
- DPRNENKPXAZQBI-UHFFFAOYSA-N alpha-Vitamin A Natural products OCC=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C DPRNENKPXAZQBI-UHFFFAOYSA-N 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 235000009566 rice Nutrition 0.000 claims description 6
- 241000251468 Actinopterygii Species 0.000 claims description 5
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 5
- 244000062793 Sorghum vulgare Species 0.000 claims description 5
- 235000021120 animal protein Nutrition 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 claims description 5
- 235000019713 millet Nutrition 0.000 claims description 5
- 239000002131 composite material Substances 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 10
- 230000035764 nutrition Effects 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 229940088594 vitamin Drugs 0.000 abstract description 3
- 229930003231 vitamin Natural products 0.000 abstract description 3
- 235000013343 vitamin Nutrition 0.000 abstract description 3
- 235000005911 diet Nutrition 0.000 abstract description 2
- 230000037213 diet Effects 0.000 abstract description 2
- 235000003715 nutritional status Nutrition 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 235000019640 taste Nutrition 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract 3
- 238000013329 compounding Methods 0.000 abstract 2
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 35
- 235000019634 flavors Nutrition 0.000 description 35
- 150000001875 compounds Chemical class 0.000 description 11
- 239000003814 drug Substances 0.000 description 9
- 229960003975 potassium Drugs 0.000 description 8
- 229940091258 selenium supplement Drugs 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 6
- 241000209094 Oryza Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 102000007584 Prealbumin Human genes 0.000 description 4
- 108010071690 Prealbumin Proteins 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 235000019605 sweet taste sensations Nutrition 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 235000019175 phylloquinone Nutrition 0.000 description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 2
- 229960001898 phytomenadione Drugs 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 101000766307 Gallus gallus Ovotransferrin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 201000003102 mental depression Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention belongs to the field of formula foods for special medical purposes, and particularly relates to a powder type total-nutrient formula food for patients suffering from tumors. The powder type total-nutrient formula food disclosed by the invention is prepared from carbohydrate, protein, fat, dietary fibers, complex vitamins, complex mineral substances and a sweetening agent. Through screening and compounding of raw materials, the composition proportion of three functional substances of the protein, the carbohydrate and the fat is reasonable, the powder type total-nutrient formula food conforms to metabolism characteristics of patients suffering from the tumors, and the metabolism requirements of the patients can be met. Sweetening agent ingredients are added into the formula of the powder type total-nutrient formula food disclosed by the invention, so that the taste of products is improved, and the powder type total-nutrient formula food is easily accepted by the patients suffering from the tumors. The powder type total-nutrient formula food disclosed by the invention also contains all vitamins and mineral substances required by human bodies, the compounding ratio of nutrition is comprehensive and balanced, the powder type total-nutrient formula food can be used as nutritional supplement for the diet of the patients suffering from tumors and can also be used as a single nutrition source of the patients suffering from the tumors, the nutritional status of the patients is improved, and the physical recovery of the patients suffering from the tumors is facilitated.
Description
Technical field
The invention belongs to special medicine purposes formula food field, be specifically related to the full nutritional formulas of a kind of powder-type tumour.
Background technology
Special medicine purposes formula food be in order to satisfied feed is limited, Disorder of Digestion and A orption, metabolic disorder or particular disease states crowd to the special requirement of nutrient or meals, the formula food that special processing is formulated.Tumor patient is because the disorder of the consumption of tumour, own metabolism, tumour are on factors such as the impact of appetite and mental depressions, quite high with the malnutritive incidence taking Body weight loss as feature.Within 2010, the national malignant tumor incidence of disease is 235.23/10 ten thousand, and the underfed incidence of malignant tumor patient, more than 50%, about has the malnutritive tumor patient of about 140,000 to need to carry out nutritional support every year.
The market scale in the current special medicine purposes formula food whole world is probably 560 ~ 64,000,000,000 yuans, is increasing every year with the speed of 6%.The scale about 600,000,000 yuans of the special medical usage formula food of China, is equivalent to 1% of the whole world, but its development rapidly, and average growth rate reaches 37%.The promulgation of " special medicine purposes formula food general rule " and " special medicine purposes formula food Good Manufacture Practice ", for the development of China's special medicine purposes formula food brings opportunity, be expected to improve domestic depending on unduly and abuse clinically to parenteral nutrition.
The market share of China's special medicine purposes formula food more than 90% is occupied for a long time by trans-corporations such as knob enlightening West Asia, Fresenius, Abbott Laboratories, domestic manufacturer's quantity is few, strength is weak, product is single, specific aim is poor and it is slow to update, and cannot meet the need of market.Meanwhile, because the predecessor of China's special medicine purposes formula food is EA, generally take into account oral, tube feed two kinds and take mode, the flavour of product is out in the cold.
Summary of the invention
The object of the invention is to single for current domestic special medicine purposes formula product, specific aim is poor, products taste and the not good problem of local flavor, provides the formula of the full nutritional formulas of a kind of powder-type tumour.
Object of the present invention is achieved through the following technical solutions: the full nutritional formulas of a kind of powder-type tumour, be made up of carbohydrate, protein, fat, dietary fiber, B B-complex, composite mineral matter and sweetener, every 100g weight portion, comprises following nutritional labeling:
Ingredient names | Content | Ingredient names | Content |
Carbohydrate | 58~62g | Pantothenic acid | 1.4~1.7mg |
Protein | 17~19g | Vitamin C | 75~85mg |
Fat | 9~11g | Biotin | 11~13μg |
Dietary fiber | 1.0~1.4g | Sodium | 430~450mg |
Vitamin A | 200~220μg | Potassium | 585~605mg |
Vitamin D | 3.8~4.8μg | Copper | 223~247μg |
Vitamin E | 4.0~4.6mg | Magnesium | 91~107mg |
Vitamin K 1 | 22~25μg | Iron | 4.2~4.9mg |
Cobastab 1 | 0.65~0.75mg | Zinc | 4.1~4.8mg |
Cobastab 2 | 0.65~0.75mg | Manganese | 215~240μg |
Cobastab 6 | 0.65~0.75mg | Calcium | 285~315mg |
Cobastab 12 | 0.65~0.75μg | Phosphorus | 204~226mg |
Nicotinic acid | 3.8~4.2mg | Iodine | 33.9~39.4μg |
Folic acid | 0.19~0.21mg | Selenium | 22.5~27.5μg |
Described carbohydrate source in but one or more the composition be not limited in millet powder, rice meal, puffed oat powder.
Described protein source in but to be not limited in lactalbumin, fish scale collagen, soybean protein isolate, soy peptide powder two or more composition.
Described adipose-derived in but be not limited to the composition of sunflower oil, linseed oil and medium chain triglyceride.
Described dietary fiber sources in but be not limited to FOS.
Described sodium mainly exists with the form of natrium citricum.The used in amounts of selected compounds is converted into the content of sodium element.
Described potassium mainly exists with the form of potassium citrate.The used in amounts of selected compounds is converted into the content of potassium element.
Described copper exists with the form of copper sulphate.The used in amounts of selected compounds is converted into the content of copper.
Described magnesium exists with the form of magnesium sulfate.The used in amounts of selected compounds is converted into the content of magnesium elements.
Described iron exists with the form of ferric pyrophosphate.The used in amounts of selected compounds is converted into the content of ferro element.
Described zinc exists with the form of zinc gluconate.The used in amounts of selected compounds is converted into the content of Zn-ef ficiency.
Described manganese exists with the form of manganese sulfate.The used in amounts of selected compounds is converted into the content of manganese element.
Described calcium mainly exists with the form of calcium monohydrogen phosphate.The used in amounts of selected compounds is converted into the content of calcium constituent.
Described phosphorus mainly exists with the form of calcium monohydrogen phosphate.The used in amounts of selected compounds is converted into the content of P elements.
Described iodine exists with the form of KI.The used in amounts of selected compounds is converted into the content of I.
Described selenium exists with the form of sodium selenite.The used in amounts of selected compounds is converted into the content of selenium element.
Described sweetener is stevioside.
Described sweetener weight portion 50 ~ 60mg.
The present invention is by the screening of raw material, and its three large energy supply matter protein, carbohydrate, fatty proportion of composing are reasonable, meet the metabolic characteristic of tumor patient, can meet the metabolic demand of patient.Containing appropriate protein, carbohydrate, fat, dietary fiber in the present invention's formula, vitamin also containing needed by human body and mineral matter, nutrition-allocated proportion is comprehensively balanced, can be used as the nutritional supplementation of tumor patient diet, also can be used as the single source of nutrition of tumor patient, effectively can improve the nutrition condition of patient.
Protein of the present invention is the composition of animal protein and vegetable protein, and it is rich in essential amino acid, and amino acid composition, close to human amino acid's composition, is conducive to the utilization of body tissue.On the one hand, vegetable protein and animal protein combinationally use, and avoid the problem of the nutrition aspects such as the Amino acid profile ratio that single protein source brings is unreasonable, a certain specific amino acids of low, the easy shortage of body utilization rate.On the other hand, the lactalbumin added as protein source, fish scale collagen, soybean protein isolate, soy peptide powder all have its special smell, vegetable protein and animal protein combinationally use a large amount of interpolations avoiding single raw material, are conducive to improving product flavour.Refer to the flavour evaluation experimental of the full nutritional formulas of following a kind of powder-type tumour.
One, experiment purpose
By sensory evaluation, evaluate the flavour of the full nutritional formulas of a kind of powder-type tumour adding separate sources protein.
Two, materials and methods
1, research object
The full nutritional formulas of a kind of powder-type tumour of 12 groups of interpolation separate sources protein, refers to table 1.
Table 113 group adds the full nutritional formulas of a kind of powder-type tumour of separate sources protein
Other components in above 13 groups of full nutritional formulas of a kind of powder-type tumour outside isolating protein are: rice meal 40g, millet powder 20g, medium chain triglyceride 5g, sunflower oil 3g, linseed oil 2g, FOS 1.2g, dehydroretinol 20 μ g, vitamine D4 .8 μ g, vitamin E 4.6mg, vitamin K1 25 μ g, vitaminB10 .75mg, vitamin B2 0.75mg, vitamin B6 0.75mg, vitamin B12 0.75 μ g, nicotinic acid 4.2mg, folic acid 0.21mg, pantothenic acid 1.7mg, vitamin C 85mg, biotin 13 μ g, sodium 450mg, potassium 605mg, copper 247 μ g, magnesium 107mg, iron 4.9mg, zinc 4.8mg, manganese 240 μ g, calcium 315mg, phosphorus 226mg, iodine 39.4 μ g, selenium 27.5 μ g, stevioside 52mg.
2, experimental technique
Random selecting 20 persons of judging, mark according to standards of grading to the flavour of above 13 groups of full nutritional formulas of a kind of powder-type tumour, and by Multiple range test, carry out group difference analysis.
3, standards of grading
Flavour standards of grading for the full nutritional formulas of powder-type tumour, in table 2.
Table 2 flavour standards of grading
score | flavor characteristics |
0-1 | product has the strong distinctive smell of cow's milk fishy smell, fishlike smell, beany flavor or enzymolysis product, and bitter taste etc., make us unhappy, and product flavour is difficult to accept. |
2-3 | product is the distinctive smell of cow's milk fishy smell, fishlike smell, beany flavor or enzymolysis product slightly, but smell is not obvious, can accept, and product flavour is better. |
4-5 | product without bad flavour, pleasant. |
Three, experimental result
To the flavour appraisal result of 13 groups of full nutritional formulas of a kind of powder-type tumour in table 3.From following table, when being used alone a kind of protein raw material, product flavour is poor, is difficult to make us accepting.And when using two or more protein raw material, product flavour obtains extremely obviously improving, along with protein raw material uses increasing of kind, the scoring of its flavour is in rising trend.By flavour appraisal result and the flavour appraisal result significant difference using two kinds and two or more protein raw material group of a kind of protein raw material of the known use of Multiple range test group.
The flavour appraisal result of the full nutritional formulas of a kind of powder-type of table 313 group tumour
Group | Scoring and the result of multiple comparisons |
1 | 0.40±0.25 A |
2 | 0.35±0.24 A |
3 | 0.20±0.19 A |
4 | 0.15±0.13 A |
5 | 3.65±0.87 B |
6 | 3.75±0.83 B |
7 | 3.90±0.83 B |
8 | 3.85±0.98 B |
9 | 3.95±0.77 B |
10 | 3.95±0.37 B |
11 | 4.05±0.68 B |
12 | 4.05±0.68 B |
13 | 4.45±0.26 BC |
Note: the group difference of mark same letter is not remarkable, the group difference of the different letter of mark is remarkable.
In fat of the present invention, medium chain triglyceride content accounts for more than 50% of total fat mass, and medium chain triglyceride hydrolysis rate is fast, easily decomposes, and absorbs fast, can be patient's Quick energizing quantity, meet the requirement that tumor patient energy requirement is high.
Dietary fiber of the present invention is FOS, and FOS belongs to prebiotics, has the effect promoting the minority beneficial bacterium flourish such as Bifidobacterium, and significantly can suppress the breeding of harmful bacteria, improve intestinal microecology in large intestine, promotes that alimentary canal is healthy.FOS also has and improves lipid-metabolism, reduces serum cholesterol, improves immunity, suppresses, pre-preventing tumor and promote the effect that the mineral matter elements such as calcium magnesium absorb.
Sweetener stevioside of the present invention is high sweetener, and addition is little, and is not absorbed by the body, and does not cause the blood glucose fluctuation of tumor patient while bringing happy sweet taste for product.Meanwhile, suitable sweetener addition, to the improvement successful of the full nutritional formulas flavour of a kind of powder-type tumour.Refer to following different stevioside addition to the improvement effect analysis of the full nutritional formulas flavour of a kind of powder-type tumour.
One, experiment purpose
By sensory evaluation, evaluate the improvement effect of different stevioside addition to the full nutritional formulas flavour of a kind of powder-type tumour.
Two, materials and methods
1, research object
The full nutritional formulas of a kind of powder-type tumour of 7 groups of interpolation separate sources protein, refers to table 4.
The full nutritional formulas of a kind of powder-type tumour of the different stevioside addition of table 47 group
Group | Stevioside addition |
1 | 20mg/100g |
2 | 30mg/100g |
3 | 40mg/100g |
4 | 50mg/100g |
5 | 60mg/100g |
6 | 70mg/100g |
7 | 80mg/100g |
Other components in above 7 groups of full nutritional formulas of a kind of powder-type tumour except stevioside are: rice meal 40g, millet powder 20g, lactalbumin 5g, fish scale collagen 4g, soybean protein isolate 5g, soy peptide powder 4g, medium chain triglyceride 5g, sunflower oil 3g, linseed oil 2g, FOS 1.2g, dehydroretinol 20 μ g, vitamine D4 .8 μ g, vitamin E 4.6mg, vitamin K1 25 μ g, vitaminB10 .75mg, vitamin B2 0.75mg, vitamin B6 0.75mg, vitamin B12 0.75 μ g, nicotinic acid 4.2mg, folic acid 0.21mg, pantothenic acid 1.7mg, vitamin C 85mg, biotin 13 μ g, sodium 450mg, potassium 605mg, copper 247 μ g, magnesium 107mg, iron 4.9mg, zinc 4.8mg, manganese 240 μ g, calcium 315mg, phosphorus 226mg, iodine 39.4 μ g, selenium 27.5 μ g.
2, experimental technique
Random selecting 20 persons of judging, mark according to standards of grading to the flavour of above 7 groups of full nutritional formulas of a kind of powder-type tumour, and by Multiple range test, carry out group difference analysis.
3, standards of grading
Flavour standards of grading for the full nutritional formulas of powder-type tumour, in table 5.
Table 5 flavour standards of grading
score | flavor characteristics |
0-1 | product is without obvious sweet taste or excessively sweet, and make us unhappy, flavour is poor. |
2-3 | product sweet taste is slightly light or slightly heavy, and flavour is general. |
4-5 | product sweet taste is moderate, and flavour is good. |
Three, experimental result
To the flavour appraisal result of 7 groups of full nutritional formulas of a kind of powder-type tumour in table 6.
Table 6 is marked to the flavour of 7 groups of full nutritional formulas of a kind of powder-type tumour
Group | Scoring and the result of multiple comparisons |
1 | 0.60±0.25 A |
2 | 1.70±0.41 B |
3 | 3.00±0.74 BC |
4 | 4.10±0.41 C |
5 | 4.25±0.40 C |
6 | 2.20±0.59 B |
7 | 0.50±0.37 A |
Note: the group difference of mark same letter is not remarkable, the group difference of the different letter of mark is remarkable.
As seen from the above table, along with the increase of stevioside addition, the flavour scoring of the full nutritional formulas of a kind of powder-type tumour is in rear downward trend of first rising.According to the result of multiple comparisons, when the addition of stevioside is 50mg/100g, 60mg/100g two levels, product flavour is good, organizes significant difference with other.The addition determining stevioside in the full nutritional formulas of a kind of powder-type tumour according to the above results is 50 ~ 60mg/100g.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further detail, but embodiments of the present invention are not limited thereto.
Embodiment 1
The full nutritional formulas of a kind of powder-type of the present invention tumour comprises the following nutrient compositions of weight proportion: rice meal 58g, lactalbumin 10g, soybean protein isolate 9g, medium chain triglyceride 6g, sunflower oil 3g, linseed oil 2g, FOS 1.4g, dehydroretinol 00 μ g, vitamine D3 .8 μ g, vitamin E 4.0mg, vitamin K
122 μ g, Cobastab
10.65mg, Cobastab
20.65mg, Cobastab
60.65mg, Cobastab
120.65 μ g, nicotinic acid 3.8mg, folic acid 0.19mg, pantothenic acid 1.4mg, vitamin C 75mg, biotin 11 μ g, sodium 430mg, potassium 585mg, copper 223 μ g, magnesium 91mg, iron 4.2mg, zinc 4.1mg, manganese 215 μ g, calcium 285mg, phosphorus 204mg, iodine 33.9 μ g, selenium 22.5 μ g, stevioside 60mg.
Embodiment 2
The full nutritional formulas of a kind of powder-type of the present invention tumour comprises the following nutrient compositions of weight proportion: rice meal 40g, millet powder 20g, lactalbumin 5g, fish scale collagen 4g, soybean protein isolate 5g, soy peptide powder 4g, medium chain triglyceride 5g, sunflower oil 3g, linseed oil 2g, FOS 1.2g, dehydroretinol 20 μ g, vitamine D4 .8 μ g, vitamin E 4.6mg, vitamin K
125 μ g, Cobastab
10.75mg, Cobastab
20.75mg, Cobastab
60.75mg, Cobastab
120.75 μ g, nicotinic acid 4.2mg, folic acid 0.21mg, pantothenic acid 1.7mg, vitamin C 85mg, biotin 13 μ g, sodium 450mg, potassium 605mg, copper 247 μ g, magnesium 107mg, iron 4.9mg, zinc 4.8mg, manganese 240 μ g, calcium 315mg, phosphorus 226mg, iodine 39.4 μ g, selenium 27.5 μ g, stevioside 50mg.
Embodiment 3
The full nutritional formulas of a kind of powder-type of the present invention tumour comprises the following nutrient compositions of weight proportion: puffed oat powder 62g, lactalbumin 8g, soybean protein isolate 5g, soy peptide powder 4g, medium chain triglyceride 5g, sunflower oil 2g, linseed oil 2g, FOS 1.0g, dehydroretinol 10 μ g, vitamine D4 .3 μ g, vitamin E 4.3mg, vitamin K
123.5 μ g, Cobastab
10.70mg, Cobastab
20.70mg, Cobastab
60.70mg, Cobastab
120.70 μ g, nicotinic acid 4.0mg, folic acid 0.20mg, pantothenic acid 1.56mg, vitamin C 80mg, biotin 12 μ g, sodium 440mg, potassium 595mg, copper 235 μ g, magnesium 99mg, iron 4.6mg, zinc 4.5mg, manganese 228 μ g, calcium 300mg, phosphorus 215mg, iodine 36.6 μ g, selenium 25 μ g, stevioside 55mg.
According to the ratio in embodiment 1-3, take raw material, according to the principle of equal increments, raw material being dry mixed to mixing, getting product.
Embodiment 4
One, experiment purpose
By clinical practice, the food of Evaluation operation example obtained by 1-3 is to the improvement situation of patient with breast cancer's nutrition condition of carrying out surgical operation therapy.
Two, materials and methods
1, research object
Oncology accepts patient with breast cancer 40 example of surgical operation therapy, 36 ~ 55 years old age, 46.2 ± 5.3 years old mean age.
2, experimental technique
Oncology accepts patient with breast cancer 40 example of surgical operation therapy, postoperative edible this product---the full nutritional formulas of powder-type tumour 15 days continuously, eating method: every day three times, each 50 grams, the 150ml that adds water is mixed with after pasty state edible, probes into the improvement effect of the full nutritional formulas of powder-type tumour to postoperative tumor patient nutrition condition and patient's immunity.
Use table of random number that patient is evenly distributed to test group and control group, test group eats the full nutritional formulas of tumour obtained by embodiment 1, and control group uses the albumen powder suitable with embodiment 1 product heat.
3, evaluation index
Constitutional index (BMI), seralbumin (ALB), serum transferrin (TF), prealbumin (PA).
Check contrast two groups of patient's nutritive indexs and immune indexes by t, it is that difference is remarkable that p value is greater than 0.05, and p value is significant difference lower than 0.05, and p value is pole significant difference lower than 0.01.
Three, experimental result
1, two groups of patient's nutritive index experimental results
Table 7 liang group patient nutritive index experimental result
Note: * represents significant difference, * * represents pole significant difference.
As known from Table 7, Post operation eats the patient of the product obtained by embodiment 1, its constitutional index (BMI), seralbumin (ALB), prealbumin (PA) are compared with control group, all significantly rise, illustrate that the improvement of the full nutritional formulas of a kind of powder-type tumour to Nutritional Status of Patients that the present invention obtains is obvious.
Above-described embodiment is the present invention's preferably embodiment; but embodiments of the present invention are not restricted to the described embodiments; change, the modification done under other any does not deviate from Spirit Essence of the present invention and principle, substitute, combine, simplify; all should be the substitute mode of equivalence, be included within protection scope of the present invention.
Claims (9)
1. the full nutritional formulas of powder-type tumour, is characterized in that: the full nutritional formulas of described a kind of powder-type tumour is made up of carbohydrate, protein, fat, dietary fiber, B B-complex, composite mineral matter and sweetener; Weight portion 58 ~ the 62g of described carbohydrate; Weight portion 17 ~ the 19g of described protein; Weight portion 9 ~ the 11g of described fat; Weight portion 1.0 ~ the 1.4g of described dietary fiber; Described B B-complex comprises the following component of weight portion: dehydroretinol 00 ~ 220 μ g, vitamine D3 .8 ~ 4.8 μ g, vitamin E 4.0 ~ 4.6mg, vitamin K
122 ~ 25 μ g, Cobastab
10.65 ~ 0.75mg, Cobastab
20.65 ~ 0.75mg, Cobastab
60.65 ~ 0.75mg, Cobastab
120.65 ~ 0.75 μ g, nicotinic acid 3.8 ~ 4.2mg, folic acid 0.19 ~ 0.21mg, pantothenic acid 1.4 ~ 1.7mg, vitamin C 75 ~ 85mg, biotin 11 ~ 13 μ g; Described composite mineral matter comprises the following component of weight portion: sodium 430 ~ 450mg, potassium 585 ~ 605mg, copper 223 ~ 247 μ g, magnesium 91 ~ 107mg, iron 4.2 ~ 4.9mg, zinc 4.1 ~ 4.8mg, manganese 215 ~ 240 μ g, calcium 285 ~ 315mg, phosphorus 204 ~ 226mg, iodine 33.9 ~ 39.4 μ g, selenium 22.5 ~ 27.5 μ g; Described sweetener weight portion 50 ~ 60mg.
2. the full nutritional formulas of a kind of powder-type tumour according to claim 1, is characterized in that: described carbohydrate is one or more the composition in rice meal, millet powder, puffed oat powder.
3. the full nutritional formulas of a kind of powder-type tumour according to claim 1, is characterized in that: described protein is the composition of animal protein and vegetable protein.
4. the full nutritional formulas of a kind of powder-type tumour according to claim 3, is characterized in that: described animal protein is one or more the composition in lactalbumin, fish scale collagen.
5. the full nutritional formulas of a kind of powder-type tumour according to claim 3, is characterized in that: described vegetable protein is one or both the composition in soybean protein isolate, soy peptide powder.
6. the full nutritional formulas of a kind of powder-type tumour according to claim 1, is characterized in that: described fat is the composition of sunflower oil, linseed oil and medium chain triglyceride.
7. the full nutritional formulas of a kind of powder-type tumour according to claim 1, is characterized in that: in described composition, medium chain triglyceride content accounts for more than 50% of total fat mass.
8. the full nutritional formulas of a kind of powder-type tumour according to claim 1, is characterized in that: described dietary fiber is FOS.
9. the full nutritional formulas of a kind of powder-type tumour according to claim 1, is characterized in that: described sweetener is stevioside.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510947496.8A CN105533696A (en) | 2015-12-17 | 2015-12-17 | Powder type total-nutrient formula food for patients suffering from tumors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510947496.8A CN105533696A (en) | 2015-12-17 | 2015-12-17 | Powder type total-nutrient formula food for patients suffering from tumors |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105533696A true CN105533696A (en) | 2016-05-04 |
Family
ID=55813691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510947496.8A Pending CN105533696A (en) | 2015-12-17 | 2015-12-17 | Powder type total-nutrient formula food for patients suffering from tumors |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105533696A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106072537A (en) * | 2016-06-18 | 2016-11-09 | 江苏阜丰生物科技有限公司 | A kind of full nutritional formulas for tumor patients |
CN106107984A (en) * | 2016-07-02 | 2016-11-16 | 威海御膳坊生物科技有限公司 | A kind of full nutritional formulas of tumor patient |
CN106509722A (en) * | 2016-11-08 | 2017-03-22 | 安徽省纽斯康生物工程有限公司 | Nutritional fruit and vegetable powder capable of preventing tumors and preparation method thereof |
CN107440088A (en) * | 2016-06-01 | 2017-12-08 | 华仁药业股份有限公司 | Improve operation, the nutrients and preparation method thereof of chemicotherapy tumor patient immunity |
CN108185437A (en) * | 2017-12-29 | 2018-06-22 | 北京康爱营养科技股份有限公司 | A kind of full nutrient formulation powder of tumour and preparation method thereof |
CN108378357A (en) * | 2018-02-28 | 2018-08-10 | 彭友同 | A kind of dietotherapy powder and preparation method thereof for eliminating late tumor pain |
CN108378377A (en) * | 2018-05-08 | 2018-08-10 | 山东理工大学 | The preparation method and applications of cervical carcinoma full nutrition formula food |
CN108991500A (en) * | 2018-07-02 | 2018-12-14 | 邦世迪(广东)医用食品股份有限公司 | A kind of tumour patient full nutrition formula food |
CN109619552A (en) * | 2018-12-05 | 2019-04-16 | 贾志丹 | Suitable for the nutrition treatment type formula and preparation method of tumor patient, purposes |
CN110338411A (en) * | 2019-08-22 | 2019-10-18 | 广州欧普康特医食品有限公司 | A kind of food compositions and preparation method thereof for tumor disease |
CN114259045A (en) * | 2022-01-04 | 2022-04-01 | 烟台大学 | Sea cucumber intestine and egg nutrition supplement for tumor patients and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1439299A (en) * | 2003-03-18 | 2003-09-03 | 华瑞制药有限公司 | Intestinal absorbing fully nutrient emulsion for phymatostio patient |
CN103330215A (en) * | 2013-07-11 | 2013-10-02 | 西安力邦临床营养有限公司 | Nutrition formula food applicable to tumor patient |
CN105029404A (en) * | 2015-04-13 | 2015-11-11 | 劲膳美生物科技股份有限公司 | Medical formula food for tumor |
-
2015
- 2015-12-17 CN CN201510947496.8A patent/CN105533696A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1439299A (en) * | 2003-03-18 | 2003-09-03 | 华瑞制药有限公司 | Intestinal absorbing fully nutrient emulsion for phymatostio patient |
CN103330215A (en) * | 2013-07-11 | 2013-10-02 | 西安力邦临床营养有限公司 | Nutrition formula food applicable to tumor patient |
CN105029404A (en) * | 2015-04-13 | 2015-11-11 | 劲膳美生物科技股份有限公司 | Medical formula food for tumor |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107440088A (en) * | 2016-06-01 | 2017-12-08 | 华仁药业股份有限公司 | Improve operation, the nutrients and preparation method thereof of chemicotherapy tumor patient immunity |
CN106072537A (en) * | 2016-06-18 | 2016-11-09 | 江苏阜丰生物科技有限公司 | A kind of full nutritional formulas for tumor patients |
CN106107984A (en) * | 2016-07-02 | 2016-11-16 | 威海御膳坊生物科技有限公司 | A kind of full nutritional formulas of tumor patient |
CN106509722A (en) * | 2016-11-08 | 2017-03-22 | 安徽省纽斯康生物工程有限公司 | Nutritional fruit and vegetable powder capable of preventing tumors and preparation method thereof |
CN108185437A (en) * | 2017-12-29 | 2018-06-22 | 北京康爱营养科技股份有限公司 | A kind of full nutrient formulation powder of tumour and preparation method thereof |
CN108378357A (en) * | 2018-02-28 | 2018-08-10 | 彭友同 | A kind of dietotherapy powder and preparation method thereof for eliminating late tumor pain |
CN108378377A (en) * | 2018-05-08 | 2018-08-10 | 山东理工大学 | The preparation method and applications of cervical carcinoma full nutrition formula food |
CN108991500A (en) * | 2018-07-02 | 2018-12-14 | 邦世迪(广东)医用食品股份有限公司 | A kind of tumour patient full nutrition formula food |
CN109619552A (en) * | 2018-12-05 | 2019-04-16 | 贾志丹 | Suitable for the nutrition treatment type formula and preparation method of tumor patient, purposes |
CN110338411A (en) * | 2019-08-22 | 2019-10-18 | 广州欧普康特医食品有限公司 | A kind of food compositions and preparation method thereof for tumor disease |
CN114259045A (en) * | 2022-01-04 | 2022-04-01 | 烟台大学 | Sea cucumber intestine and egg nutrition supplement for tumor patients and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105533696A (en) | Powder type total-nutrient formula food for patients suffering from tumors | |
CN102687750B (en) | Weight losing and meal replacement protein type solid beverage | |
CN104256595B (en) | A kind of many polymerizers of whole protein type enteral nutrition | |
CN104544432B (en) | Samara oil compound protein solid beverage and method for preparing same | |
CN103653170B (en) | Stachyose probiotics solid beverage | |
CN106213495A (en) | Wt .-loss type meal replacement powder and preparation method thereof | |
CN106418544A (en) | Protein and probiotic composite food with weight losing effect | |
CN108991535A (en) | A kind of high dietary-fiber, low-carbon water meal replacement powder and preparation method thereof | |
CN104172147A (en) | Se-enriched natural nutritional food and preparation method thereof | |
CN106912612A (en) | Generation meal milk shake powders and preparation method thereof | |
CN105707707A (en) | Super quinoa nutrition powder for pregnant and lying-in women | |
CN103689375A (en) | Noodle formula suitable for diabetic patients and processing method of the noodle | |
EP1351584A2 (en) | Nutritional composition for a bone condition | |
CN103564262B (en) | Hog grower feed | |
CN108719977A (en) | A kind of breast cancer nutraceutical and preparation method thereof | |
Soto et al. | Bioavailability of calcium from enriched meat products using Caco-2 cells | |
CN103637098B (en) | Instant soybean protein puffed food | |
CN101112210B (en) | Onion biological fermentation emulsion and the producing method thereof | |
CN104799281A (en) | Method for producing compound peanut milk suitable for old people | |
CN101791078A (en) | Food replacing diet for controlling weight | |
CN101716003B (en) | Dietary fiber series oral liquid | |
CN108968008A (en) | A kind of children's pregnant woman salt and preparation method thereof | |
CN108432879A (en) | A kind of complex function Sourbean milk that can remove beany flavor | |
CN104041553B (en) | The edible nutritive health biscuit of a kind of applicable the elderly | |
CN102511882A (en) | Red jujube thick syrup beneficial for improving growth and development |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160504 |